PLAYSTUDIOS, Inc.
MYPS Nasdaq Services-Prepackaged Software Financials FY2019βFY2025
What PLAYSTUDIOS, Inc. does
No business description yet.
- Legal name
- PLAYSTUDIOS, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 16, 2026
- Accession Β· CIK
- 0001823878-26-000020
0001823878
Revenue and margins
PLAYSTUDIOS, Inc. had $235M of revenue in fiscal 2025, down 18.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $25.4M in fiscal 2025, 10.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
PLAYSTUDIOS, Inc. returned $3.5M to shareholders in fiscal 2025, 14% of free cash flow. The diluted share count fell 2.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably PLAYSTUDIOS, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $214M | $134M | $133M | $109M | $105M |
| Current ratio | 8.1x | 5.2x | 3.8x | 3.0x | 3.1x |
| Quick ratio | 8.1x | 5.2x | 3.8x | 3.0x | 3.1x |
| Total assets | $335M | $352M | $366M | $323M | $291M |
| Total liabilities | $31.4M | $49.7M | $78.0M | $78.2M | $62.8M |
| Shareholders' equity | $303M | $302M | $288M | $245M | $228M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 7 | 2 / 7 | 3 / 7 | 4 / 7 | 4 / 7 |
| Accruals ratio | β | β26.5% | β9.9% | β14.9% | β19.8% | β21.6% | β17.9% |
| Altman Z'' | β | 5.87 | 14.58 | 8.65 | 5.97 | 4.27 | 4.65 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $239M | $270M | $287M | $290M | $311M | $289M | $235M |
| Net interest income | β$0.3M | β$0.1M | β$0.2M | $1.9M | $4.9M | β | β |
| Research and development | $39.0M | $51.7M | $61.3M | $63.3M | $70.3M | $67.7M | $58.4M |
| Operating income | $17.1M | $10.3M | β$3.0M | β$28.1M | β$10.5M | β$32.9M | β$23.9M |
| Pretax income | $17.6M | $11.1M | $10.5M | β$23.6M | β$2.5M | β$27.3M | β$26.7M |
| Income tax | $4.0M | β$1.7M | β$0.3M | β$5.8M | $16.9M | $1.4M | $1.9M |
| Net income | $13.6M | $12.8M | $10.7M | β$17.8M | β$19.4M | β$28.7M | β$28.6M |
| Diluted EPS | $0.14 | $0.12 | $0.09 | β$0.14 | β$0.15 | β$0.22 | β$0.23 |
| Diluted shares | 0.10B | 0.10B | 0.12B | 0.13B | 0.13B | 0.13B | 0.13B |
| Cash flow | |||||||
| Cash from operations | $36.1M | $48.4M | $33.9M | $33.4M | $51.7M | $45.7M | $26.3M |
| Capital expenditure | $4.3M | $1.8M | $2.0M | $12.0M | $6.3M | $4.0M | $1.0M |
| Free cash flow | $31.8M | $46.6M | $31.9M | $21.4M | $45.4M | $41.8M | $25.4M |
| Depreciation and amortization | $2.6M | $2.8M | $2.8M | $4.7M | $5.5M | $4.9M | $3.9M |
| Stock-based compensation | $5.9M | $3.5M | $4.5M | $17.7M | $18.7M | $18.1M | $14.1M |
| Acquisitions | β | $0.0M | $0.0M | $70.4M | $0.0M | $3.4M | $0.0M |
| Share buybacks | $6.2M | $0.0M | $0.0M | $4.3M | $15.5M | $31.2M | $3.5M |
| Dividends and buybacks | $6.2M | $0.0M | $0.0M | $4.3M | $15.5M | $31.2M | $3.5M |
| Balance sheet | |||||||
| Cash and short-term investments | $31.0M | $48.9M | $214M | $134M | $133M | $109M | $105M |
| Current assets | β | $77.8M | $242M | $176M | $175M | $147M | $135M |
| Current liabilities | β | $33.8M | $29.9M | $34.2M | $46.0M | $49.4M | $43.2M |
| Property and equipment, net | β | $6.2M | $5.3M | $17.5M | $17.5M | $16.1M | $13.4M |
| Goodwill | β | $5.1M | $5.1M | $47.1M | $47.1M | $52.2M | $52.2M |
| Intangible assets | β | $1.6M | $18.8M | $77.2M | $111M | $91.0M | $76.4M |
| Total assets | β | $134M | $335M | $352M | $366M | $323M | $291M |
| Total liabilities | β | $38.4M | $31.4M | $49.7M | $78.0M | $78.2M | $62.8M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $80.3M | $96.1M | $303M | $302M | $288M | $245M | $228M |
| Margins | |||||||
| Operating margin | 7.2% | 3.8% | β1.0% | β9.7% | β3.4% | β11.4% | β10.2% |
| EBITDA margin | 8.2% | 4.9% | β0.1% | β8.1% | β1.6% | β9.7% | β8.5% |
| Net margin | 5.7% | 4.7% | 3.7% | β6.1% | β6.2% | β9.9% | β12.2% |
| FCF margin | 13.3% | 17.2% | 11.1% | 7.4% | 14.6% | 14.4% | 10.8% |
| Net interest share of revenue | β0.1% | β0.1% | β0.1% | 0.7% | 1.6% | β | β |
| Returns | |||||||
| Return on capital employed | β | 10.3% | β1.0% | β8.8% | β3.3% | β12.0% | β9.7% |
| Return on equity | 17.0% | 14.5% | 5.4% | β5.9% | β6.6% | β10.8% | β12.1% |
| Return on assets | β | 9.5% | 4.6% | β5.2% | β5.4% | β8.3% | β9.3% |
| Return on tangible equity | 17.0% | 14.3% | 3.8% | β10.0% | β14.9% | β28.3% | β28.9% |
| Growth | |||||||
| Revenue growth | β | 12.7% | 6.5% | 1.0% | 7.1% | β6.9% | β18.8% |
| Net income growth | β | β5.9% | β16.2% | β265.6% | β | β | β |
| EPS growth | β | β14.3% | β25.0% | β255.6% | β | β | β |
| FCF growth | β | 46.4% | β31.5% | β32.8% | 112.0% | β8.0% | β39.2% |
| Share count change | β | 6.4% | 21.0% | 2.8% | 3.6% | β2.7% | β2.9% |
| Financial health | |||||||
| Current ratio | β | 2.3x | 8.1x | 5.2x | 3.8x | 3.0x | 3.1x |
| Quick ratio | β | 2.3x | 8.1x | 5.2x | 3.8x | 3.0x | 3.1x |
| Capital allocation | |||||||
| Capex / revenue | 1.8% | 0.7% | 0.7% | 4.1% | 2.0% | 1.4% | 0.4% |
| Stock comp / revenue | 2.5% | 1.3% | 1.6% | 6.1% | 6.0% | 6.3% | 6.0% |
| Payouts / FCF | 19.4% | 0.0% | 0.0% | 20.0% | 34.0% | 74.7% | 13.8% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 4.0 | 2.0 | 3.0 | 4.0 | 4.0 |
| Altman Z'' | β | 5.9 | 14.6 | 8.6 | 6.0 | 4.3 | 4.7 |
| Accruals ratio | β | β26.5% | β9.9% | β14.9% | β19.8% | β21.6% | β17.9% |
Source: SEC EDGAR XBRL filings (CIK 0001823878). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.